Cyclops®
Pre-filled
dry Powder inhaler
Cyclops® is a state-of-the-art, easy to use, pre-filled DPI that is developed by PureIMS for inhalation powders.
Because of its simple yet
sophisticated proprietary design it can be produced in a cost-effective way.
Cyclops® is available in single & multi use versions.
Upon inhalation it uses the patient’s breath to disperse the dry powder formulation into small particles appropriately sized for deep lung deposition. Cyclops® has several advantages compared to standard-of-care DPIs across key therapeutic areas. These attributes enable the hygienic and effective use on a worldwide scale. One product, Colistin Cyclops®, is already available to patients and reimbursed under a named patient regimen for the treatment of cystic fibrosis.
HIGHLY PREFERRED BY PATIENTS
LATEST NEWS
CYCLOPS® Dry Powder Inhaler Now Available Nationwide in the Netherlands Thanks to Agreement Between Fagron and PureIMS
Fagron and PureIMS have joined forces to make CYCLOPS® dry
September 26, 2024
International Congress of Parkinson’s Disease and Movement Disorders 2024 – poster on Levodopa Cyclops®
Please check out our latest poster (#708) presenting clinical study
September 18, 2024
Cyclops® in Inhalation Technology magazine!
Dry powder inhalers for rescue applications Check out this fascinating
May 28, 2024
PureIMS gears up for abbreviated registration of Levodopa Cyclops® against OFF episodes in Parkinson’s disease with the successful completion of a comparative pharmacokinetic study
Roden, the Netherlands, January 18, 2024 PureIMS, a pharmaceutical company
January 18, 2024
PureIMS winning the LIFE Science Innovation Award!
Tuesday September 26 was an exciting day for the PureIMS team. Not
September 27, 2023